Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

abz-pharma gmbh - geschäftsanschrift - (4238075) - captopril - tablette - teil 1 - tablette; captopril (19545) 50 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

janssen-cilag gmbh (8009839) - itraconazol - kapsel - itraconazol (23401) 100 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

clinigen healthcare b.v. (8181225) - dexrazoxan - pulver zur herstellung einer infusionslösung - teil 1 - pulver zur herstellung einer infusionslösung; dexrazoxan (26073) 500 milligramm

Europäische Union - Deutsch - EMA (European Medicines Agency)

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische mittel - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Europäische Union - Deutsch - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastische mittel - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Europäische Union - Deutsch - EMA (European Medicines Agency)

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische mittel - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Europäische Union - Deutsch - EMA (European Medicines Agency)

amneal pharma europe ltd - levodopa, carbidopa - parkinson krankheit - anti-parkinson-medikamente - symptomatische behandlung von erwachsenen patienten mit parkinson-krankheit.

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - peginterferonum beta-1a - 63 mcg/0,5 ml - peginterferonum beta-1a 63 µg l-arginini hydrochloridum, natrii acetas trihydricus, säure aceticum glaciale, polysorbatum 20, wasser iniectabilia q.s. zu einer lösung anstelle von 0,5 ml. - multiple sklerose - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - peginterferonum beta-1a - 94 mcg/0,5 ml - peginterferonum beta-1a 94 µg l-arginini hydrochloridum, natrii acetas trihydricus, säure aceticum glaciale, polysorbatum 20, wasser iniectabilia q.s. zu einer lösung anstelle von 0,5 ml. - multiple sklerose - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - peginterferonum beta-1a - 125 mcg/0,5 ml - peginterferonum beta-1a 125 µg, l-arginini hydrochloridum, natrii acetas trihydricus, säure aceticum glaciale, polysorbatum 20, wasser iniectabilia q.s. zu einer lösung anstelle von 0,5 ml. - multiple sklerose - biotechnologika